Deuterium depletion can decrease the expression of C-myc Ha-ras and p53 gene in carcinogen-treated mice

In Vivo

Volumn 14, Issue 3, 2000, Pages 437-439

  Gyöngyi, Zoltán ^a   Somlyai, Gábor ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b HYD Ltd for R and D   (Hungary)

Author keywords

Deuterium, deuterium depletion, deuterium depleted water, DMBA, c myc, Ha ras, p53, gene expression

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; DEUTERIUM; MYC PROTEIN; PROTEIN P53; RAS PROTEIN; RNA;

ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DEPLETION; GENE EXPRESSION; KIDNEY; LIVER; LUNG; LYMPH NODE; MOUSE; NONHUMAN; SPLEEN; THYMUS; TUMOR PROMOTION;

EID: 1642602443     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Collins CJA Bowman NS (eds.): Isotope Effects in Chemical Reactions. Van Nostrand Reinhold, New York, 1971.
2. Wiberg KB: The deuterium isotope effect. Chem Rev 55: 713-43, 1955.
3. Jancsó G and Van Hook WA: Condensed phase isotope effects (especially vapor pressure isotope effects). Chem Rev 74: 689-750, 1974.
4. Rundel PW, Ehleringer JR and Nagy KA: Stable isotopes in ecological research. Springer, New York, 1988.
5. Katz JJ and Crespi HL: Isotope effects in biological systems. In: Collins CJ, Bowman NS (eds.): Isotope effects in chemical reactions. Van Nostrand Reinhold, New York: 286-363, 1971.
6. Yurtsever Y and Gat JR: Stable isotope hydrology. Edited by Gat JR and Gonfiantini R: International Atomic Energy Agency, Vienna, 103-42, 1981.
7. Somlyai G, Jancsó G, Jákli G, Vass K, Barna B, Lakics V and Gaál T: Naturally occurring deuterium is essential for the normal growth rate of cells. FEBS Lett 317: 1-4, 1993.
8. Somlyai G, Láskay G, Berkényi T, Jákli and Jancsó G: Naturally occurring deuterium may have a central role in cell signalling. In: Heys JR, Melillo DG (eds.): Synthesis and applications of isotopically labelled compounds. John Wiley & Sons Ltd, 137-41, 1998.
9. Somlyai G, Laskay G, Berkényi T, Galbács Z, Galbács G, Kiss AS, Jákli Gy and Jancsó G: The biological effects of deuterium-depleted water, a possible new tool in cancer therapy. Z Onkol J Oncol 30: 91-94, 1998.
10. Ember I, Kiss I and Pusztai Zs: Effect of 7,12-dimethylbez(α)anthracene on onco/suppressor gene action in vivo: a short-term experiment. Anticancer Res 18: 445-7, 1998.
11. Pusztai Zs, Selypes A and Ember I: Short-term effects of 1-nitropyrene on chromosomes and on oncogene/tumor suppressor gene expression in vivo. Anticancer Res 18: 4489-92, 1998.
12. Ember I, Kiss I and Vermes E: Early effect of cyclophosphamide on oncogene expression in vivo. In Vivo 12: 201-8, 1998.
13. Ember I and Kiss I: In vivo effects of cyclophosphamide on oncogene and suppressor gene expression in a "follow-up study". Anticancer Res 17: 3593-7, 1997.
14. Ember I, Kiss I, Ghodratollah NA Raposa T: Effect of ABVD therapeutic protocol on oncogene and tumor suppressor gene expression in CBA/CA mice. Anticancer Res 18: 1149-52, 1998.
15. Ember I, Raposa T, Varga Cs, Herceg L and Kiss I: Carcinogenic effects of cytostatic protocols in CBA/Ca mice. In Vivo 9: 65-9, 1995.
16. Ember I, Raposa T, Varga Cs and Kiss I: Effect of different cytostatic protocols on oncogene expression in CBA/Ca mice. Anticancer Res 15: 1285-8, 1995.
17. Ember I, Kiss I, Raposa T, Nowrasteh G and Matolcsy A: In vivo effects of CHOP protocol on onco and suppressor gene expression: follow-up study. In Vivo 12: 489-94, 1998.
18. Ember I, Kiss I and Raposa T: In vivo effects of COPP protocol on onco- and suppressor gene expression in "follow-up study". In Vivo 11:399-402, 1997.
19. Ember I, Kiss I and Malovics I: Oncogene and tumor suppressor gene expression changes in person exposed to ethylene oxide. Eur J Cancer Prev 7: 167-8, 1998.
20. Ember I, Kiss I, Gömbkötó Gy, Muller E and Szeremi M: Oncogene and suppressor gene expression as a biomarker for ethylene oxide exposure. Cancer Det Prev 22: 241-5, 1998.
21. Ember I, Kiss IA and Faluhelyi Zs: Gene expression changes as potential biomarkers of tumour bearing status in humans. Eur J Cancer Prev 7: 347-8, 1998.
22. Pusztai Zs, Dezsenyi T, Kiss T, Gecsei Gy and Ember I: Detection of elevated oncogene expressions in brain tumours and their macroscopically healthy surrounding tissues. Eur J Cancer Prev 7: 417-9, 1998.
23. Selypes A and Ember I: Investigation of the total RNA expression of the genes c-myc and p53 in the testes of mice treated with cadmium. Central Eur J Occup Env Med 4: 36-44, 1998.
24. Kozma L, Kiss I, Nagy A, Szakal S and Ember I: Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma. Cancer Lett 111: 127-31, 1997.
25. Hajdu J, Kozma L, Kiss I, Szentkereszty Z, Szakall S and Ember I: Is the presence of distant metastasis associated with c-myc amplification in gastric cancer? Acta Chir Hung 36: 119-21, 1997.
26. Kozma L, Kiss I, Ember I and Kertai P: Studies on accute myelomonotic leukemia in LBFl rats. Cancer Lett 68: 185-92, 1993.
27. Kozma L, Kiss I, Szakall S and Ember I: Investigation of c-myc oncogene amplification in colorectal cancer. Cancer Lett 81: 165-9, 1994.
28. Ember I, Kiss I and Nowrasteh G: Different H2 haplotypes have a strong influence on oncogene action. Anticancer Res 19: 1181-5, 1999.
29. Chomczynski P and Sacchi N: Single step method for RNA isolation by acidguanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-9, 1987.
30. Renz M and Kurz C: A colorimetric method for DNA hybridization. Nucl Acids Res 12: 3435-44, 1984.
31. Brandt-Rauf PW: Biomarkers of gene expression: growth factors and oncoproteins. Environ Health Perspect 105: 807-16, 1997.
32. MacArthur LH, Clarke MF and Westin EH: Malignant transformation of NIH 3T3 fibroblast by human c-sis is dependent upon the level of oncogene expression. Mol Carcinog 5: 311-9, 1992.
33. Rimoldi D, Srikantan V, Wilson VL, Bassin RH and Samid D: Increased sensitivity of nontumorigenic fibroblasts expressing ras or myc oncogenes to malignant transformation induced by 5-aza-2'-deoxycytidine. Cancer Res 51: 324-30, 1991.
34. Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP and Pirruccello SJ: c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Ann Thorac Surg 60: 1583-91, 1995.
35. Wang DG, Johnston CF and Buchanan KD: Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis. Cancer 80: 668-75, 1997.
36. Omori H, Kuroda M, Naora H, Takeda H, Nio Y, Otani H and Tamura K: Deuterium oxide (heavy water) accelerates actin assembly in vitro and changes microfilament distribution in cultured cells. Eur J Cell Biol 74: 273-80, 1997.
37. Lamprecht J, Schroeter D and Pawaletz N: Mitosis arrested by deuterium oxide. Light microscopic, immunofluorescence and ultrastructural characterization. Eur J Cell Biol 51: 303-12, 1990.
38. Edington BV, Whelan SA and Hightower LE: Inhibition of heat shock (stress) protein induction by deuterium oxide and glycerol: additional support for the abnormal protein hypothesis of induction J Cell Physiol 139: 219-28, 1989.